company background image
IRMD

IRadimed NasdaqCM:IRMD Stock Report

Last Price

US$39.22

Market Cap

US$492.8m

7D

8.6%

1Y

16.4%

Updated

15 Aug, 2022

Data

Company Financials +
IRMD fundamental analysis
Snowflake Score
Valuation0/6
Future Growth2/6
Past Performance4/6
Financial Health6/6
Dividends0/6

IRMD Stock Overview

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally.

IRadimed Corporation Competitors

Price History & Performance

Summary of all time highs, changes and price drops for IRadimed
Historical stock prices
Current Share PriceUS$39.22
52 Week HighUS$55.92
52 Week LowUS$28.90
Beta1.0
1 Month Change6.58%
3 Month Change19.61%
1 Year Change16.41%
3 Year Change86.85%
5 Year Change286.40%
Change since IPO296.16%

Recent News & Updates

Jul 29

iRadimed Non-GAAP EPS of $0.26 beats by $0.02, revenue of $12.7M beats by $0.06M

iRadimed press release (NASDAQ:IRMD): Q2 Non-GAAP EPS of $0.26 beats by $0.02. Revenue of $12.7M (+29.6% Y/Y) beats by $0.06M. Q3 Outlook: For the third quarter 2022, the company expects to report revenue of $13.1 million to $13.3 million, vs. consensus of $12.71M; GAAP diluted earnings per share of $0.21 to $0.24, and non-GAAP diluted earnings per share of $0.22 to $0.25 vs. consensus of $0.21. FY 2022 Guidance: The company increased its full year 2022 financial guidance and expects to report revenue of $52.5 million to $53.2 million, vs. prior guidance of $51.4 million to $52.2 million vs. consensus of $52.14 million. GAAP diluted earnings per share of $0.89 to $0.95, vs. prior outlook of  $0.82 to $0.90; and non-GAAP diluted earnings per share of $0.96 to $1.03, vs. prior guidance range of $0.91 to $1.01 vs. consensus of $0.89.

Shareholder Returns

IRMDUS Medical EquipmentUS Market
7D8.6%2.3%3.6%
1Y16.4%-19.6%-9.6%

Return vs Industry: IRMD exceeded the US Medical Equipment industry which returned -19.1% over the past year.

Return vs Market: IRMD exceeded the US Market which returned -10.2% over the past year.

Price Volatility

Is IRMD's price volatile compared to industry and market?
IRMD volatility
IRMD Average Weekly Movement6.7%
Medical Equipment Industry Average Movement9.4%
Market Average Movement7.7%
10% most volatile stocks in US Market16.9%
10% least volatile stocks in US Market3.2%

Stable Share Price: IRMD is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 7% a week.

Volatility Over Time: IRMD's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1992110Roger Susihttps://www.iradimed.com

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible patient vital signs monitoring system. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories.

IRadimed Corporation Fundamentals Summary

How do IRadimed's earnings and revenue compare to its market cap?
IRMD fundamental statistics
Market CapUS$492.80m
Earnings (TTM)US$12.20m
Revenue (TTM)US$47.81m

40.4x

P/E Ratio

10.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
IRMD income statement (TTM)
RevenueUS$47.81m
Cost of RevenueUS$10.64m
Gross ProfitUS$37.17m
Other ExpensesUS$24.98m
EarningsUS$12.20m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)0.97
Gross Margin77.75%
Net Profit Margin25.51%
Debt/Equity Ratio0%

How did IRMD perform over the long term?

See historical performance and comparison